SCHEMBL23486286

SCHEMBL23486286

CCOC(=O)c1nnsc1Cc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ILK Q13418 1/20 0.59
▸ TSHR P16473 1/20 0.48
▸ CYP19A1 P11511 4/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ ALDH1A1 P00352 4/20 0.46
▸ MAPT P10636 2/20 0.46
▸ HTT P42858 1/20 0.46
▸ TP53 P04637 1/20 0.46
▸ ALOX12 P18054 1/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ LMNA P02545 2/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23486284 0.92 ILK (0.54) ILKTSHRCYP19A1MEN1KMT2A
SCHEMBL22609346 0.90 ILK (0.52) ILKTSHRALDH1A1MAPTHTT
SCHEMBL22609269 0.86 ILK (0.47) ILKTSHRMEN1KMT2AALDH1A1
SCHEMBL23453738 0.86 ILK (0.47) ILKTSHRCYP19A1MEN1KMT2A
SCHEMBL23486383 0.81 ALDH1A1 (0.47) ILKTSHRALDH1A1MAPTSMN1; SMN2
SCHEMBL23453737 0.80 MAPT (0.43) ILKTSHRALDH1A1MAPTHTT
SCHEMBL6815148 0.77 ILK (0.61) ILKTSHRCYP19A1MEN1KMT2A
SCHEMBL3933156 0.76 ALDH1A1 (0.56) MEN1KMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL22005508 0.74 ILK (0.51) ILKTSHRMEN1KMT2AALDH1A1
SCHEMBL5146303 0.74 ILK (1.00) ILKTSHRMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210171503-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF ORFAN BIOTECH SL (ES) 2021-06-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210171503-A1 GLYCOLATE OXIDASE INHIBITORS AND USE THEREOF PNPO, XDH, GLS ILK 3208/4885TSHR 1767/4885CYP19A1 1395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback